CG Oncology, Inc. Common stock (CGON)
Healthcare
Biotechnology
71.20 $
-2.5%
vs. previous close
Closing price · As of: 31. Jul 2026
CG Oncology, Inc. Common stock (CGON) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -57 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11 | -11 | -16 | -26 | -16 | -16 | -21 | -29 | -28 | -39 | -36 | -57 | -160 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.4 | 0.8 | 0.8 | 2.3 | |
| 0.2 | 0.4 | 0.8 | 1.5 | 2.2 | 2.6 | 5.0 | 5.2 | 7.0 | 7.3 | 7.2 | 6.5 | 28 | |
| 0.3 | 0.2 | 2.2 | -8.4 | 3.0 | 3.4 | 4.9 | 0.5 | 8.7 | -2.9 | -4.0 | -5.8 | -4.0 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.1 | 0.0 | 0.3 | 0.4 | |
| 103 | -163 | 17 | -307 | -36 | 32 | 11 | -187 | 1.4 | 15 | -76 | -335 | -394 | |
| – | – | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | – | – | |
| -15 | 106 | -2.9 | 403 | 0.0 | 2.2 | 223 | 0.5 | -0.3 | 54 | 99 | 393 | 546 | |
| 77 | -68 | -2.0 | 69 | -52 | 18 | 214 | -216 | -27 | 31 | -13 | 1.2 | -7.8 | |
| -11 | -11 | -16 | -26 | -16 | -16 | -21 | -29 | -28 | -39 | -36 | -57 | -160 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.